FIELD: medicine, neurology, phytotherapy, pharmacy. SUBSTANCE: invention relates to the development of agents used in treatment of nervous diseases. Invention proposes agent for treatment of epilepsy and convulsive syndrome comprising water-soluble chitosan, dry extract of medicinal plants and vehicle taken in the ratio 1:15:4, respectively. Dry extract comprises motherwort quinquelobate herb, valerian officinal rhizomes, common wormwood herb, Saint-John's-wort perforated herb, melissa officinal herb, haw-thorn blood-red flowers, marjoram officinal herb and oats in stage of milky-wax ripeness taken in the ratio = 2:2:1:1:2:2:1:4, respectively. Agent can be prepared as 0.5 g tablet and prescribed for oral intake in the dose 1 tablet, 3 times per a day, 15 min before eating for 4-26 weeks. Intake of this agent provides stable therapeutic effect and prolongs intra-attack period disease. EFFECT: valuable medicinal properties of agent. 3 cl, 3 ex
| Title | Year | Author | Number | 
|---|---|---|---|
| SPECIES OF MEDICINAL HERBS FOR TREATMENT OF NEUROSES AND NEURASTHENIA | 2000 | 
 | RU2174005C1 | 
| AGENT FOR TREATMENT OF INSOMNIA | 1990 | 
 | RU2012347C1 | 
| REMEDY FOR TREATMENT OF CARDIOVASCULAR DISEASES | 2008 | 
 | RU2391996C1 | 
| PHYTOTRANQUILISER | 2011 | 
 | RU2452507C1 | 
| "TABLETS FOR MIND" MEDICATION | 2010 | 
 | RU2429001C1 | 
| MEDICINAL HERBAL TEA FOR CARDIOVASCULAR DISEASES | 2012 | 
 | RU2484843C1 | 
| AGENT FOR PHYTOCORRECTION | 1995 | 
 | RU2089213C1 | 
| AGENT AND METHOD OF POST-INFARCTION CARDIOSCLEROSIS TREATMENT | 2002 | 
 | RU2204403C1 | 
| 77 HERBS PHYTOTEA | 2016 | 
 | RU2664459C2 | 
| CHILDREN'S SEDATIVE SPECIES | 2001 | 
 | RU2211701C2 | 
Authors
Dates
2003-05-20—Published
2002-04-29—Filed